Latest Deep vein thrombosis Stories
Findings presented at American Heart Association's Scientific Sessions add to growing body of data supporting safety and effectiveness of PRADAXA RIDGEFIELD, Conn., Nov.
The Firm is representing individuals in Xarelto lawsuits that allege use of the blood-thinning medication caused serious complications, including uncontrollable internal bleeding. New
The Firm is evaluating Xarelto lawsuits on behalf of patients who experienced uncontrollable internal bleeding, strokes, deep vein thrombosis, pulmonary embolism, or other complications allegedly
- RE-VERSE AD(TM) is being conducted in more than 35 countries with aim to enroll 250 patients RIDGEFIELD, Conn., Nov. 10, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Xarelto Page Launched to Monitor Lawsuits Being Filed on Behalf of Patients Who Allege the Blood Thinner Causes Severe Internal Bleeding and Uncontrollable Bleeding New
An increasing number of lawsuits allege that Xarelto, a blood thinning medication, may cause uncontrolled bleeding which can lead to serious internal bleeding or death. New
Largest observational study of a newer oral anticoagulant, with more than 134,000 elderly patients, published in Circulation RIDGEFIELD, Conn., Nov. 3, 2014 /PRNewswire/ -- A U.S.
The Firm is evaluating Xarelto lawsuits on behalf of individuals who experienced uncontrollable internal bleeding, blood clots, and other serious complications, allegedly due to their use of the
The portable VenaPro system helps prevent post-operative Deep Vein Thrombosis Irving, Texas (PRWEB) October 21, 2014 The leading podiatry specialists
The National Blood Clot Alliance will continue its long-standing collaboration with the Centers for Disease Control and Prevention (CDC), as it has been awarded another five-year CDC Cooperative Agreement